Jamie Gault joined Scioderm as Vice President, Regulatory Affairs and Quality in February 2015. Ms. Gault brings more than 25 years of experience in Regulatory Affairs and Quality, having most recently served as Global Head, Regulatory Affairs at Novella Clinical. Ms. Gault has a broad regulatory background and strong knowledge of the technical aspects of new drug approval, and has designed and implemented regulatory strategies at pharma companies and behalf of clients. Ms. Gault has implemented global regulatory programs across multiple therapeutic areas, including dermatology, oncology, cardiology, neurology and antivirals. She began her career as a bench chemist and has progressed through CMC, regulatory compliance and regulatory affairs positions at pharma, biotech and service organizations. Prior to Scioderm, Ms. Gault held positions at Novella Clinical, Fulcrum Pharma, Clinsys Clinical Research, BioCryst Pharmaceuticals, Inc., Voyager Pharmaceuticals, Duke Clinical Research Institute, Glaxo Wellcome Inc. and Sphinx Pharmaceutical Corporation. She holds a B.S. in chemistry from Fairmont State College and has held a Regulatory Affairs Certified Credential from the Regulatory Affairs Certification Board (RAC) since 1996.